Prof. Armin Wolf, Phd Email & Phone Number

Schopfheim, BW, DE

Schlieren, Zurich, Switzerland

Schlieren, Zurich, Switzerland

Consulting company that offers translational toxicology solutions to pharma and biotech

Schlieren, Zurich, Switzerland

Overseeing the company´s R&D programs in liver safety, liver disease, islet biology and oncology. Development of specific applications as needed by customers. Development of specific DILI applications for each phase of the Pharma life cycle from Discovery to Clinics. Founder and leader of the international X-Species DILI validation consortium with 9.

Beerse (Belgium), La Jolla (CA), Spring House (PA)

Setting-up a global Mechanistic and Investigative Toxicology organization at 3 sites with the scientific focus in Predictive Toxicology, Biomarker and Mechanistic Toxicology

Basel, Switzerland

Discovery and Investigative Safety (DIS) within Preclinical Safety Department (PCS). Conducting complex mechanistic in vivo and in vitro toxicity studies. Safety profiling of developmental compounds and drugs in all development phases. Safety biomarker discovery and validation.

Basel, Switzerland

Increasing responsibility as Group Head, Section Head and Global Section Head within the field of Investigative Toxicology/Preclinical Safety and Biomarker Development Department at Novartis Pharma AG Basel. In parallel Part Time Project Representative (PTR) to support early compound development.

Basel, Switzerland

Setting-up of various In Vitro Toxicology models and In Vitro Toxicity Screens, particularly for liver, kidney and heart.

Professor Of Toxicology In Drug Discovery & Development

Department of Chemistry, Institute of Toxicology

Board Certified Toxicologist

Postdoc, Cancer Research

Institute of Pathobiochemistry: DKFZ grant to investigate oxygen activation by liver tumor promoters

Phd, Cancer Research

Institute of Biochemistry: Mechanisms of Chemical Hepatocarcinogenesis

Diploma, Chemistry And Biology

Thesis in Biochemistry